Treatment of childhood anxiety disorders: what is the place for antidepressants?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2012-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1517/14656566.2012.642864PMID 22149367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmental epidemiology of anxiety disorders.

  2012cited by this paper
• Pharmacotherapy for anxiety disorders in children and adolescents.

  2011cited by this paper
• Sertraline Treatment of Children and Adolescents With Posttraumatic Stress Disorder: A Double-Blind, Placebo-Controlled Trial

  2010cited by this paper
• Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications

  2010cited by this paper
• Pharmacotherapy for anxiety disorders in children and adolescents.

  2009influential reference
• Research update.

  2009cited by this paper
• The American Psychiatric Publishing Textbook of Psychopharmacology

  2009cited by this paper
• A randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)

  2009cited by this paper
• A study of the sedative effect of home-administered oral diazepam for the dental treatment of children.

  2009cited by this paper
• Psychopharmacology for children: from off label use to registration.

  2009cited by this paper
• One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden.

  2009cited by this paper
• Anxiety disorders during childhood and adolescence: origins and treatment.

  2009influential reference
• Tricyclic and Tetracyclic Drugs

  2009cited by this paper
• Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

  2008cited by this paper
• Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study.

  2008cited by this paper
• Distorted cognition and pathological anxiety in children and adolescents

  2008cited by this paper
• Combining and sequencing medication and cognitive-behaviour therapy for childhood anxiety disorders

  2008cited by this paper
• Parents' perceptions of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders.

  2007cited by this paper
• Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.

  2007cited by this paper
• A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.

  2007cited by this paper
• Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

  2007cited by this paper
• Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

  2007cited by this paper
• Normal and abnormal fear and anxiety in children and adolescents

  2007cited by this paper
• A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms.

  2007cited by this paper
• Research review: a neuroscience framework for pediatric anxiety disorders.

  2007cited by this paper
• SET-C versus fluoxetine in the treatment of childhood social phobia.

  2007cited by this paper
• Psychopharmacology interventions for pediatric anxiety disorders: a research update.

  2006cited by this paper
• Psychotherapy of Childhood Anxiety Disorders: A Meta-Analysis

  2006influential reference
• Phobic and Anxiety Disorders in Children and Adolescents: A Clinician's Guide to Effective Psychosocial and Pharmacological Interventions

  2006cited by this paper
• Family issues in child anxiety: attachment, family functioning, parental rearing and beliefs.

  2006cited by this paper
• Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.

  2006cited by this paper
• Family cognitive behavioral therapy for children and adolescents with clinical anxiety disorders.

  2006cited by this paper
• Family cognitive behavioral therapy for child anxiety disorders.

  2006cited by this paper
• A literature review on off-label drug use in children

  2005cited by this paper
• The Role of Temperament in the Etiology of Child Psychopathology

  2005cited by this paper
• Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.

  2005cited by this paper
• Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial.

  2005cited by this paper
• Should Parents Be Co-Clients in Cognitive-Behavioral Therapy for Anxious Youth?

  2005cited by this paper
• Childhood Fears and Phobias: Assessment and Treatment.

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

  2004cited by this paper
• Integrated Psychosocial and Pharmacological Treatment

  2004cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

  2004cited by this paper
• Phobic and Anxiety Disorders in Children and Adolescents

  2004cited by this paper
• Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders.

  2004cited by this paper
• Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up.

  2004cited by this paper
• Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• Prevalence and development of psychiatric disorders in childhood and adolescence.

  2003cited by this paper
• Cognitive-behavioral therapy for children with anxiety disorders in a clinical setting: no additional effect of a cognitive parent training.

  2003cited by this paper
• A comparison of completers and noncompleters of exposure-based cognitive and behavioral treatment for phobic and anxiety disorders in youth.

  2003cited by this paper
• Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders.

  2003cited by this paper
• Fluoxetine for the treatment of childhood anxiety disorders.

  2003cited by this paper
• Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

  2002cited by this paper
• The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties.

  2002cited by this paper
• The pharmacological treatment of childhood anxiety disorders

  2002cited by this paper
• Treating Children and Adolescents with Selective Serotonin Reuptake Inhibitors: How Long Is Appropriate?

  2002influential reference
• Cognitive behavioural therapy for children and adolescents with anxiety disorders: clinical research advances

  2002cited by this paper
• Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial.

  2002cited by this paper
• Altered dendritic spine density in animal models of depression and in response to antidepressant treatment

  2001cited by this paper
• Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

  2001cited by this paper
• Cognitive-behavioral treatment of anxiety disorders in children: long-term (6-year) follow-up.

  2001cited by this paper
• Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

  2001cited by this paper
• The Developmental Psychopathology of Anxiety

  2001cited by this paper
• Evaluating the FRIENDS Program: A Cognitive-Behavioral Group Treatment for Anxious Children and Their Parents

  2001cited by this paper
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

  2001cited by this paper
• Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.

  2001cited by this paper
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

  2001cited by this paper
• Examining Outcome Variability: Correlates of Treatment Response in a Child and Adolescent Anxiety Clinic

  2001cited by this paper
• Imipramine plus cognitive-behavioral therapy in the treatment of school refusal.

  2000cited by this paper
• Group and Individual Cognitive-Behavioral Treatments for Youth with Anxiety Disorders: A Randomized Clinical Trial

  2000cited by this paper
• Predictors of outcome in exposure-based cognitive and behavioral treatments for phobic and anxiety disorders in children*

  2000cited by this paper
• Cognitive-behavioral group treatments in childhood anxiety disorders: the role of parental involvement.

  1999cited by this paper
• Persistently Increased Density of Serotonin Transporters in the Frontal Cortex of Rats Treated with Fluoxetine During Early Juvenile Life

  1999cited by this paper
• Pathophysiology of childhood anxiety disorders.

  1999cited by this paper
• TOC EN NIÑOS Y ADOLESCENTES

  1999cited by this paper
• OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual

  1999cited by this paper
• Sertraline in Children and Adolescents with Obsessive-Compulsive Disorder

  1999cited by this paper
• Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.

  1998cited by this paper
• Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor.

  1998influential reference
• Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

  1998cited by this paper
• The role of parental anxiety in the treatment of childhood anxiety.

  1998cited by this paper
• Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders.

  1998cited by this paper
• Empirically supported treatments for children with phobic and anxiety disorders: current status.

  1998cited by this paper
• Therapy for youths with anxiety disorders: a second randomized clinical trial.

  1997cited by this paper
• Family treatment of childhood anxiety: a controlled trial.

  1996cited by this paper
• Anxiety disorders in children and adolescents

  1995cited by this paper
• Treating anxiety disorders in children: results of a randomized clinical trial.

  1994cited by this paper
• The Yale-Brown Obsessive-Compulsive Scale: measures of internal consistency.

  1994cited by this paper
• Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.

  1994cited by this paper
• Clonazepam in childhood anxiety disorders.

  1994cited by this paper
• Anxiety disorders in children and adolescents: research, assessment and intervention (second edition)

  1993cited by this paper
• Another sudden death in a child treated with desipramine.

  1993cited by this paper
• Imipramine treatment of children with separation anxiety disorder.

  1992cited by this paper
• Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.

  1992cited by this paper
• Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.

  1992cited by this paper
• Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

  1992cited by this paper
• QUANTITATIVE METHODS IN PSYCHOLOGY A Power Primer

  1992cited by this paper
• The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

  1989cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

  1989cited by this paper

• A Review on Pediatric Social Phobia and Selective Mutism

  2021cites this paper
• Selective Mutism and Its Relations to Social Anxiety Disorder and Autism Spectrum Disorder

  2021cites this paper
• Current Challenges in the Diagnosis and Management of Selective Mutism in Children

  2021cites this paper
• Back to the Future: Tracing the Footsteps of Mary Cover Jones—The Treatment of Children and Adolescents With Anxiety Disorders

  2019cites this paper
• European Journal of Education Studies-ISSN 2501-1111

  2019cites this paper
• Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study

  2019cites this paper
• Selective Mutism Interventions: What Works?

  2017cites this paper
• Reducing Pediatric Anxiety through Training: an Integrative Neurocognitive Approach

  2017cites this paper
• Childhood, adolescent and adult age at onset and related clinical correlates in obsessive–compulsive disorder: a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS)

  2016cites this paper
• Children Who are Anxious in Silence: A Review on Selective Mutism, the New Anxiety Disorder in DSM-5

  2015cites this paper
• Social anxiety disorder in adolescence: How developmental cognitive neuroscience findings may shape understanding and interventions for psychopathology

  2015cites this paper
• Single-Session Cognitive Bias Modification of Interpretations Training in High-Anxious Adolescents

  2015cites this paper
• A feasibility study into the efficacy of a three session Cognitive Bias Modification for Interpretation (CBM-I) training, with Implementation Intentions (II), for adolescents experiencing high levels of social anxiety : a single-case series

  2015cites this paper
• The Scientific Legacy of Little Hans and Little Albert: Future Directions for Research on Specific Phobias in Youth

  2015cites this paper
• Anxiety Disorders and Phobias

  2014cites this paper
• Angst en angststoornissen

  2014cites this paper
• Long-Term Trend in Pediatric Antidepressant Use, 1983–2007: A Population-Based Study

  2014cites this paper
• Cognitive bias modification of interpretations: a viable treatment for child and adolescent anxiety?

  2013cites this paper
• Modifying Adolescent Interpretation Biases Through Cognitive Training: Effects on Negative Affect and Stress Appraisals

  2013cites this paper
• Obsessive-compulsive disorder in pediatrics and adolescents: Review of treatment and future directions

  2013cites this paper
• Anxiety in the Primary Classroom: A Handbook for Elementary Educators

  2013influential citation
• Reducing children's social anxiety symptoms: exploring a novel parent-administered cognitive bias modification training intervention.

  2013cites this paper
• Understanding and treating social anxiety: lessons learnt from developmental cognitive neuroscience

  2013cites this paper
• Psychotropic medication use in adolescents with intellectual disability living in the community

  2013cites this paper